Cite

HARVARD Citation

    Fediuk, D. et al. (2021). End‐to‐end application of model‐informed drug development for ertugliflozin, a novel sodium‐glucose cotransporter 2 inhibitor. CPT: pharmacometrics & systems pharmacology. pp. 529-542. [Online]. 
  
Back to record